Saturday, December 2, 2023
May 29 - 31, 2020
ASCO 2020
'Abysmal' Student Makes the Grade as Oncologist
ASCO 2020
Oncologist: I've Had Depression. Opening Up Has Rewards
ASCO 2020
Treatments Linked to Death in COVID Patients With Thoracic Cancers
ASCO 2020
Tumor Markers 'Valuable' for Relapse Detection in Rare CNS Tumors
ASCO 2020
'Unbelievably Exciting' Results in Rare Type of Breast Cancer
ASCO 2020
No OS Benefit With Gefitinib vs Chemo for EGFR + NSCLC
ASCO 2020
New Approaches Lessen Mystery of Cancer of Unknown Primary
ASCO 2020
'Hospital at Home' Cuts ED Visits and Costs for Cancer Patients
ASCO 2020
Weekly Cisplatin New Standard in Postop Head and Neck Cancer
ASCO 2020
G-CSF Cuts Febrile Neutropenia Rates in Early Breast Cancer
ASCO 2020
'Disturbing Finding' on Black Patients With Cancer in Need of Opioids
ASCO 2020
Three Years of Imatinib May Halve Death Rate in GIST
ASCO 2020
Secondary Surgery Extends OS in Recurrent Ovarian Cancer
ASCO 2020
No Role for Adjv Atezolizumab in Muscle-Invasive Bladder Cancer
ASCO 2020
A Bumpy Virtual #ASCO20; Returning to Chicago in 2021?
ASCO 2020
Germline Testing In Advanced Cancer Can Lead to Targeted Tx
ASCO 2020
Updated BEACON: Doublet as Good as Triplet in Metastatic CRC
ASCO 2020
Relugolix: Novel Drug for ADT in Advanced Prostate Cancer
ASCO 2020
Need HER2+ Testing in CRC; Trastuzumab Deruxtecan Shows Benefit
ASCO 2020
Pembrolizumab Prolonged PFS vs Brentuximab in Hodgkin Lymphoma
ASCO 2020
Oncology Care Model Reduces Costs but Savings Are Modest
ASCO 2020
Tucatinib Improves PFS, OS in HER2+ BC With Brain Metastases
ASCO 2020
Upfront Pembrolizumab Doubles PFS in MSI-H/dMMR Metastatic CRC
ASCO 2020
PPI Added to Chemo Improves Breast Tumor Response Rate
ASCO 2020
Avelumab Offers Post-Chemo Hope to Women With Rare Tumor
ASCO 2020
Adjuvant Osimertinib Extends DFS in Localized NSCLC
ASCO 2020
Active Cancer Increases Death Risk in Patients With COVID-19
ASCO 2020
Targeted Tx Improves Outcomes in High-Risk Pediatric Cancers
ASCO 2020
Moving on Up: Maintenance Therapy Extends OS in Bladder Cancer
ASCO 2020
'Staging the Aging' Cancer Benefits Proven. Payment Coming?
ASCO 2020
Quitting Smoking 2 Years Before Lung Cancer Diagnosis
ASCO 2020
New OS Data With Olaparib Support 'New Era' for Ovarian Cancer
ASCO 2020
Fewer Cancer Deaths After ACA Medicaid Expansion
ASCO 2020
ASCO Goes Ahead Online, as Conference Center Used as Hospital
Medscape Oncology© WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
'Impressive Results' From Stage III Melanoma Studies: ASCO 2020
Ovarian Cancer Trials: The Good News and the Bad News
The Oncologist's Role With Savvy Patients
When to Add Chemotherapy to IO in Lung Cancer? New Data from ASCO 2020
Breakthroughs in Immunotherapy From ASCO 2020
Breakthroughs in HCC and Liver Cancer From ASCO 2020
Colorectal Cancer Highlights from ASCO 2020
Highlights in Ovarian Cancer From ASCO 2020
Early Breast Cancer Highlights From ASCO 2020
Highlights in Non-Hodgkin Lymphoma From ASCO 2020
Key Studies in Metastatic Breast Cancer From ASCO 2020
Highlights in Non-Small Cell Lung Cancer From ASCO 2020
Surprising Results From the PALLAS Trial
Progress in Targeted Therapy for Lung Cancer: New Data
ASCO 2020: GI Cancer Highlights From David Kerr
Three Practice-Informing Breast Cancer Trials From ASCO 2020
Pembro 'New Treatment of Choice' for MSI-H/dMMR Metastatic CRC
Practice-Changing GI Cancer Highlights From Virtual ASCO 2020
ADAURA Trial: Breaking Through the Hype
Virtual ASCO Levels the Playing Field for Oncologists Everywhere
How to Prepare Yourself for a Virtual ASCO
ASCO President on 'Making Lemonade' for Virtual Annual Meeting
